Murphy Nicole
SEC CIK 1910644 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BIIB | Biogen | Head of Pharm Ops, Tech | 19.6K | $585.12 | — | 32 | 2022-02-12 | 2026-02-12 |
Most active insiders at BIIB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Singhal Priya | Head of Development | — | $665.7K |
| 2 | Minor Lloyd | Dir | — | $239.7K |
| 3 | Murphy Nicole | Head of Pharm Ops, Tech | $585.12 | — |
| 4 | Godbout Sean | CAO | — | — |
| 5 | Pangalos Menelas N | Dir | — | — |
| 6 | Grogan Jane | Head of Research | — | — |
| 7 | LANGER SUSAN | Dir | — | — |
| 8 | Keeney Adam | Head of Corp. Development | — | — |
| 9 | Izzar Rachid | Head of Gbl Product Strat | — | — |
| 10 | Patolawala Monish D | Dir | — | — |
Transactions 32
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-17 | 2026-02-12 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | P - Purchase | $195.04 | +3 | 19.6K | +0.0% | +$585.12 |
| DM | 2026-02-10 | 2026-02-06 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $201.18 | -3,339 | 15.3K | -18% | -$671.7K |
| DM | 2026-02-10 | 2026-02-06 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +8,725 | 21.0K | +71% | $0 |
| D | 2025-02-12 | 2025-02-10 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +2,272 | 14.7K | +18% | $0 |
| D | 2025-02-12 | 2025-02-10 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $142.54 | -670 | 14.1K | -5% | -$95.5K |
| DM | 2025-02-10 | 2025-02-07 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +4,042 | 13.1K | +45% | $0 |
| DM | 2025-02-10 | 2025-02-07 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $141.35 | -1,223 | 11.1K | -10% | -$172.9K |
| D | 2024-04-03 | 2024-04-01 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +240 | 9,751 | +3% | $0 |
| D | 2024-04-03 | 2024-04-01 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $214.83 | -117 | 9,634 | -1% | -$25.1K |
| DM | 2024-02-21 | 2024-02-16 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +1,260 | 9,614 | +15% | $0 |
| DM | 2024-02-21 | 2024-02-16 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $219.08 | -610 | 9,210 | -6% | -$133.6K |
| D | 2024-02-13 | 2024-02-09 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +2,272 | 9,529 | +31% | $0 |
| D | 2024-02-13 | 2024-02-09 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $240.98 | -761 | 8,768 | -8% | -$183.4K |
| D | 2024-02-09 | 2024-02-08 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +2,101 | 7,895 | +36% | $0 |
| D | 2024-02-09 | 2024-02-08 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $240.30 | -638 | 7,257 | -8% | -$153.3K |
| D | 2023-04-04 | 2023-03-31 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +239 | 5,818 | +4% | $0 |
| D | 2023-04-04 | 2023-03-31 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $278.03 | -116 | 5,702 | -2% | -$32.3K |
| D | 2023-02-22 | 2023-02-17 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +480 | 5,579 | +9% | $0 |
| D | 2023-02-22 | 2023-02-17 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $278.38 | -233 | 5,099 | -4% | -$64.9K |
| DM | 2023-02-14 | 2023-02-10 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +2,611 | 6,034 | +76% | $0 |
| DM | 2023-02-14 | 2023-02-10 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $286.30 | -1,387 | 5,694 | -20% | -$397.1K |
| 2023-01-27 | 2023-01-25 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | A - Grant | $0.00 | +1,340 | 4,108 | +48% | $0 | |
| D | 2022-12-06 | 2022-12-02 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $298.90 | -39 | 2,768 | -1% | -$11.7K |
| D | 2022-12-06 | 2022-12-02 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +131 | 2,807 | +5% | $0 |
| DM | 2022-08-03 | 2022-08-01 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $209.26 | -319 | 2,094 | -13% | -$66.8K |
| DM | 2022-08-03 | 2022-08-01 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +1,080 | 2,170 | +99% | $0 |
| D | 2022-04-05 | 2022-04-01 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | — | +239 | 1,897 | +14% | — |
| D | 2022-04-05 | 2022-04-01 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $210.65 | -84 | 1,813 | -4% | -$17.7K |
| D | 2022-02-23 | 2022-02-18 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $209.79 | -110 | 1,658 | -6% | -$23.1K |
| D | 2022-02-23 | 2022-02-18 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +371 | 1,768 | +27% | $0 |
| D | 2022-02-15 | 2022-02-12 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +263 | 1,489 | +21% | $0 |
| D | 2022-02-15 | 2022-02-12 | BIIB | Biogen | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $214.59 | -92 | 1,397 | -6% | -$19.7K |
Purchase Sale Sale after option exercise All abbreviations